Literature DB >> 26607308

In Vivo-Expressed Proteins of Virulent Leptospira interrogans Serovar Autumnalis N2 Elicit Strong IgM Responses of Value in Conclusive Diagnosis.

Veerapandian Raja1, Santhanam Shanmughapriya1, Murugesan Kanagavel1, Sergey C Artiushin2, Sridhar Velineni2, John F Timoney2, Kalimuthusamy Natarajaseenivasan3.   

Abstract

Leptospirosis is a serious zoonosis that is underdiagnosed because of limited access to laboratory facilities in Southeast Asia, Central and South America, and Oceania. Timely diagnosis of locally distributed serovars of high virulence is crucial for successful care and outbreak management. Using pooled patient sera, an expression gene library of a virulent Leptospira interrogans serovar Autumnalis strain N2 isolated in South India was screened. The identified genes were characterized, and the purified recombinant proteins were used as antigens in IgM enzyme-linked immunosorbent assay (ELISA) either singly or in combination. Sera (n = 118) from cases of acute leptospirosis along with sera (n = 58) from healthy subjects were tested for reactivity with the identified proteins in an ELISA designed to detect specific IgM responses. We have identified nine immunoreactive proteins, ArgC, RecA, GlpF, FliD, TrmD, RplS, RnhB, Lp28.6, and Lrr44.9, which were found to be highly conserved among pathogenic leptospires. Apparently, the proteins ArgC, RecA, GlpF, FliD, TrmD, and Lrr44.9 are expressed during natural infection of the host and undetectable in in vitro cultures. Among all the recombinant proteins used as antigens in IgM ELISA, ArgC had the highest sensitivity and specificity, 89.8% and 95.5%, respectively, for the conclusive diagnosis of leptospirosis. The use of ArgC and RecA in combination for IgM ELISA increased the sensitivity and specificity to 95.7% and 94.9%, respectively. ArgC and RecA thus elicited specific IgM responses and were therefore effective in laboratory confirmation of Leptospira infection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26607308      PMCID: PMC4711087          DOI: 10.1128/CVI.00509-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

1.  Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans.

Authors:  H Guerreiro; J Croda; B Flannery; M Mazel; J Matsunaga; M Galvão Reis; P N Levett; A I Ko; D A Haake
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus.

Authors:  Hildegard Etz; Duc Bui Minh; Tamás Henics; Agnieszka Dryla; Birgit Winkler; Christine Triska; Aoife P Boyd; Johannes Söllner; Walter Schmidt; Uwe von Ahsen; Michael Buschle; Steven R Gill; James Kolonay; Hanif Khalak; Claire M Fraser; Alexander von Gabain; Eszter Nagy; Andreas Meinke
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

3.  Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans.

Authors:  Raghavan U M Palaniappan; Yung-Fu Chang; S S D Jusuf; S Artiushin; John F Timoney; Sean P McDonough; Steve C Barr; Thomas J Divers; Kenneth W Simpson; Patrick L McDonough; Hussni O Mohammed
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

4.  Detection of 23 immunogenic pneumococcal proteins using convalescent-phase serum.

Authors:  G Zysk; R J Bongaerts; E ten Thoren; G Bethe; R Hakenbeck; H P Heinz
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Leptospira interrogans serovar Valbuzzi: a cause of severe pulmonary haemorrhages in the Andaman Islands.

Authors:  P Vijayachari; S C Sehgal; Marga G A Goris; W J Terpstra; R A Hartskeerl
Journal:  J Med Microbiol       Date:  2003-10       Impact factor: 2.472

6.  Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA.

Authors:  Raghavan U M Palaniappan; Yung-Fu Chang; Fahad Hassan; Sean P McDonough; Margaret Pough; Stephen C Barr; Kenneth W Simpson; Hussni O Mohammed; Sang Shin; Patrick McDonough; Richard L Zuerner; Jiaxin Qu; Bruce Roe
Journal:  J Med Microbiol       Date:  2004-10       Impact factor: 2.472

7.  Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily.

Authors:  James Matsunaga; Michele A Barocchi; Julio Croda; Tracy A Young; Yolanda Sanchez; Isadora Siqueira; Carole A Bolin; Mitermayer G Reis; Lee W Riley; David A Haake; Albert I Ko
Journal:  Mol Microbiol       Date:  2003-08       Impact factor: 3.501

8.  Detection of human leptospirosis as a cause of acute fever by capture ELISA using a Leptospira interrogans serovar Copenhageni (M20) derived antigen.

Authors:  Enrique Canal; Simon Pollett; Kristen Heitzinger; Michael Gregory; Matthew Kasper; Eric Halsey; Yocelinda Meza; Kalina Campos; Juan Perez; Rina Meza; Maruja Bernal; Alfredo Guillen; Tadeusz J Kochel; Benjamin Espinosa; Eric R Hall; Ryan C Maves
Journal:  BMC Infect Dis       Date:  2013-09-20       Impact factor: 3.090

9.  Identification of seroreactive proteins of Leptospira interrogans serovar copenhageni using a high-density protein microarray approach.

Authors:  Carolina Lessa-Aquino; Camila Borges Rodrigues; Jozelyn Pablo; Rie Sasaki; Algis Jasinskas; Li Liang; Elsio A Wunder; Guilherme S Ribeiro; Adam Vigil; Ricardo Galler; Douglas Molina; Xiaowu Liang; Mitermayer G Reis; Albert I Ko; Marco Alberto Medeiros; Philip L Felgner
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17

10.  Human leptospirosis in The Federated States of Micronesia: a hospital-based febrile illness survey.

Authors:  Susannah Colt; Boris I Pavlin; Jacob L Kool; Eliaser Johnson; Judith P McCool; Alistair J Woodward
Journal:  BMC Infect Dis       Date:  2014-04-07       Impact factor: 3.090

View more
  6 in total

1.  Heterologous Expression, Purification and Characterization of an Oligopeptidase A from the Pathogen Leptospira interrogans.

Authors:  Prasannan V Anu; Madathiparambil G Madanan; Ananthakrishnan J Nair; Gangaprasad A Nair; Govinda Pillai M Nair; Perumana R Sudhakaran; Padikara K Satheeshkumar
Journal:  Mol Biotechnol       Date:  2018-04       Impact factor: 2.695

2.  Peptide specific monoclonal antibodies of Leptospiral LigA for acute diagnosis of leptospirosis.

Authors:  Murugesan Kanagavel; Santhanam Shanmughapriya; Kayanam Vijaya Lalitha Aishwarya; Karuppiah Ponmurugan; Kasi Murugan; Naif Abdullah Al-Dhabi; Kalimuthusamy Natarajaseenivasan
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

3.  MicroRNAs Regulated by the LPS/TLR2 Immune Axis as Bona Fide Biomarkers for Diagnosis of Acute Leptospirosis.

Authors:  Charles Solomon Akino Mercy; Natarajaseenivasan Suriya Muthukumaran; Prema Velusamy; Palanisamy Bothammal; Krishnamoorthi Sumaiya; Perumal Saranya; Dianne Langford; Santhanam Shanmughapriya; Kalimuthusamy Natarajaseenivasan
Journal:  mSphere       Date:  2020-07-15       Impact factor: 4.389

4.  Construction of Genomic Library and Screening of Edwardsiella tarda Immunogenic Proteins for Their Protective Efficacy Against Edwardsiellosis.

Authors:  Palanisamy Bothammal; Mohan Ganesh; Vellaisamy Vigneshwaran; Kumarasamy Anbarasu; Karuppiah Ponmurugan; Naif Abdullah Al-Dhabi; Kalimuthusamy Natarajaseenivasan
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

5.  Assessment of Serum Macrophage Migration Inhibitory Factor (MIF) as an Early Diagnostic Marker of Leptospirosis.

Authors:  Krishnamoorthi Sumaiya; Charles Solomon Akino Mercy; Gangatharan Muralitharan; Abdurahman Hajinur Hirad; Abdullah A Alarfaj; Kalimuthusamy Natarajaseenivasan
Journal:  Front Cell Infect Microbiol       Date:  2022-02-14       Impact factor: 5.293

6.  Heterologous DNA prime-protein boost immunization with RecA and FliD offers cross-clade protection against leptospiral infection.

Authors:  Veerapandian Raja; Sankaran Sobana; Charles Solomon Akino Mercy; Bianca Cotto; Durlav Prasad Bora; Kalimuthusamy Natarajaseenivasan
Journal:  Sci Rep       Date:  2018-04-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.